Trials / Conditions / ALK Gene Rearrangement
ALK Gene Rearrangement
4 registered clinical trials studyying ALK Gene Rearrangement.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung NCT04005144 | University of California, San Francisco | Phase 1 |
| Active Not Recruiting | Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small L NCT04013542 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung NCT03707938 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery NCT02201992 | ECOG-ACRIN Cancer Research Group | Phase 3 |